Kala Pharmaceuticals, Inc. (KALA)
NASDAQ: KALA · IEX Real-Time Price · USD
6.76
-0.07 (-1.02%)
At close: Jul 19, 2024, 4:00 PM
7.05
+0.29 (4.29%)
Pre-market: Jul 22, 2024, 7:05 AM EDT
Kala Pharmaceuticals Employees
Kala Pharmaceuticals had 43 employees as of December 31, 2023. The number of employees increased by 9 or 26.47% compared to the previous year.
Employees
43
Change (1Y)
9
Growth (1Y)
26.47%
Revenue / Employee
n/a
Profits / Employee
-$919,791
Market Cap
19.04M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Aspira Women's Health | 64 |
Cara Therapeutics | 55 |
MEI Pharma | 46 |
Vincerx Pharma | 42 |
GlycoMimetics | 35 |
iBio, Inc. | 26 |
NeurAxis | 19 |
Alterity Therapeutics | 11 |
KALA News
- 7 weeks ago - KALA BIO to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference - GlobeNewsWire
- 6 months ago - KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 months ago - KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 11 months ago - KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference - GlobeNewsWire
- 1 year ago - KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire